EUVIMEDEUVIMED entdecken
Crossref

AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model‐based dose calculation algorithms in brachytherapy

Luc Beaulieu, Facundo Ballester, Domingo Granero, Åsa Carlsson Tedgren, Annette Haworth, Jessica R Lowenstein, Yunzhi Ma, Firas Mourtada, Panagiotis Papagiannis, Mark J Rivard, Frank-André Siebert, Ron S Sloboda und 5 weitere

Medical Physics · 2023-08 · 50 (8)

DOI: 10.1002/mp.16571 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Physics, online erschienen am 10.07.2023. Verfasst von Luc Beaulieu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Service de Physique Médicale et Radioprotection et Axe Oncologie du Centre de Recherche du CHU de Québec, CHU de Québec-Université Laval, Québec, Qué…. Hauptthemen laut MEDLINE: Brachytherapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, Swedish Cancer Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The introduction of model‐based dose calculation algorithms (MBDCAs) in brachytherapy provides an opportunity for a more accurate dose calculation and opens the possibility for novel, innovative treatment modalities. The joint AAPM, ESTRO, and ABG Task Group 186 (TG‐186) report provided guidance to early adopters. However, the commissioning aspect of these algorithms was described only in general terms with no quantitative goals. This report, from the Working Group on Model‐Based Dose Calculation Algorithms in Brachytherapy, introduced a field‐tested approach to MBDCA commissioning. It is based on a set of well‐characterized test cases for which reference Monte Carlo (MC) and vendor‐specific MBDCA dose distributions are available in a Digital Imaging and Communications in Medicine—Radiotherapy (DICOM‐RT) format to the clinical users. The key elements of the TG‐186 commissioning workflow are now described in detail, and quantitative goals are provided. This approach leverages the well‐known Brachytherapy Source Registry jointly managed by the AAPM and the Imaging and Radiation Oncology Core (IROC) Houston Quality Assurance Center (with associated links at ESTRO) to provide open access to test cases as well as step‐by‐step user guides. While the current report is limited to the two most widely commercially available MBDCAs and only for 192 Ir‐based afterloading brachytherapy at this time, this report establishes a general framework that can easily be extended to other brachytherapy MBDCAs and brachytherapy sources. The AAPM, ESTRO, ABG, and ABS recommend that clinical medical physicists implement the workflow presented in this report to validate both the basic and the advanced dose calculation features of their commercial MBDCAs. Recommendations are also given to vendors to integrate advanced analysis tools into their brachytherapy treatment planning system to facilitate extensive dose comparisons. The use of the test cases for research and educational purposes is further encouraged.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyRadiotherapy DosageRadiotherapy Planning, Computer-AssistedAlgorithmsResearch ReportMonte Carlo MethodRadiometry

Stichwörter der Autor:innen

Monte CarloTG-186brachytherapycommissioningdose calculationmodel-based dose calculation

Autor:innen und Institutionen

  • Service de Physique Médicale et Radioprotection et Axe Oncologie du Centre de Recherche du CHU de Québec, CHU de Québec-Université Laval, Québec, Québec, Canada.
  • Département de Physique, de Génie Physique et d'Optique et Centre de Recherche sur le Cancer, Université Laval, Québec, Québec, Canada.
  • Departamento de Física Atómica, Molecular y Nuclear, IRIMED, IIS-La Fe-Universitat de Valencia, Burjassot, Spain.
  • Department of Health, Medicine and Caring Sciences (HMV), Radiation Physics, Linköping University, Linköping, Sweden.
  • Medical Radiation Physics and Nuclear Medicine, Karolinska University Hospital, Stockholm, Sweden.
  • Department of Oncology Pathology, Karolinska Institute, Stockholm, Sweden.

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Swedish Cancer Foundation

Zitieren

APA

Beaulieu, L., Ballester, F., Granero, D., Tedgren, Å. C., Haworth, A., Lowenstein, J. R., Ma, Y., Mourtada, F., Papagiannis, P., Rivard, M. J., Siebert, F. A., Sloboda, R. S., Smith, R. L., Thomson, R. M., Verhaegen, F., Fonseca, G., & Vijande, J. (2023). AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model‐based dose calculation algorithms in brachytherapy. Medical Physics, 50(8). https://doi.org/10.1002/mp.16571

Vancouver

Beaulieu L, Ballester F, Granero D, Tedgren ÅC, Haworth A, Lowenstein JR, et al. AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model‐based dose calculation algorithms in brachytherapy. Medical Physics. 2023;50(8). doi:10.1002/mp.16571

BibTeX
@article{Beaulieu2023,
  author = {Beaulieu, Luc and Ballester, Facundo and Granero, Domingo and Tedgren, Åsa Carlsson and Haworth, Annette and Lowenstein, Jessica R and Ma, Yunzhi and Mourtada, Firas and Papagiannis, Panagiotis and Rivard, Mark J and Siebert, Frank-André and Sloboda, Ron S and Smith, Ryan L and Thomson, Rowan M and Verhaegen, Frank and Fonseca, Gabriel and Vijande, Javier},
  title = {AAPM WGDCAB Report 372: A joint AAPM, ESTRO, ABG, and ABS report on commissioning of model‐based dose calculation algorithms in brachytherapy},
  journal = {Medical Physics},
  year = {2023},
  volume = {50},
  number = {8},
  doi = {10.1002/mp.16571}
}
Kostenlos starten →